Relmada Therapeutics Inc (STU:4E2)
€ 2.76 0.04 (1.47%) Market Cap: 85.12 Mil Enterprise Value: 7.79 Mil PE Ratio: 0 PB Ratio: 1.28 GF Score: 31/100

Relmada Therapeutics Inc (STU:4E2) Transcripts

  • 1